38
Participants
Start Date
June 20, 2019
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
exercise (walking)
Exercise treatment will consist of individualized walking delivered up to 5 times weekly. This trial will evaluate one dose of exercise (i.e., \~300 mins/wk following a non-linear dosing schedule) in both cohorts. Patients will have the option to receive exercise treatment at MSK or at their residence. Home-based exercise will be implemented and monitored using a telemedicine approach (i.e.,TeleEx) established in the Exercise-Oncology (ExOnc) Service
plasma samples
Plasma samples will be obtained at baseline.
blood draw
fasting blood
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Nassau, Uniondale
Memorial Sloan Kettering Commack, Commack
LABORATORY CORPORATION OF AMERICA HOLDINGS (Data or Specimen Analysis Only), Burlington
Duke University Medical Center (Data or Specimen Analysis Only), Durham
SOMALOGIC (Data or Specimen Analysis Only), Boulder
University of California, Los Angeles (Data or Specimen Analysis Only), Los Angeles
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale
Weill Medical College of Cornell University
OTHER
University of California, Los Angeles
OTHER
Memorial Sloan Kettering Cancer Center
OTHER